Metronidazole and clarithromycin resistant Helicobacter pylori after triple agent eradication therapy including both these antibiotics.

被引：0
|
作者：
Takano, R [1 ]
Takahashi, M [1 ]
Hirakawa, J [1 ]
Takada, H [1 ]
Kuwayama, H [1 ]
机构：
[1] Dokkyo Univ Sch, Univ Hosp, Koshigaya, Japan
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3008
引用
收藏
页码：A592 / A592
页数：1
相关论文
共 50 条
  • [41] An Analysis of the High Eradication Rate for Vonoprazan-Based Triple Therapy Against Helicobacter pylori Resistant to Clarithromycin
    Ohta, Hidetoshi
    Sagawa, Tamotsu
    GASTROENTEROLOGY, 2016, 150 (04) : S677 - S677
  • [42] Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication
    De Francesco, Vincenzo
    Zullo, Angelo
    Fiorini, Giulia
    Saracino, Ilaria M.
    Pavoni, Matteo
    Vaira, Dino
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (03) : 772 - 774
  • [43] Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin
    Miehlke, S.
    Hansky, K.
    Schneider-Brachert, W.
    Kirsch, C.
    Morgner, A.
    Madisch, A.
    Kuhlisch, E.
    Baestlein, E.
    Jacobs, E.
    Bayerdoerffer, E.
    Lehn, N.
    Stolte, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (02) : 395 - 403
  • [44] Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori
    Bardhan, KD
    Morton, D
    Perry, MJ
    Sanders, DS
    Morris, P
    Rowland, A
    Thompson, M
    Mitchell, TR
    Roberts, PM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (08) : 1199 - 1204
  • [45] Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan
    Satoshi Hoshiya
    Kazuhiro Watanabe
    Kengo Tokunaga
    Akifumi Tanaka
    Hidehiko Ninomiya
    Masao Shingaki
    Takeshi Itoh
    Shozo Saito
    Hitoshi Ishida
    Shin'ichi Takahashi
    Journal of Gastroenterology, 2000, 35 (1) : 10 - 14
  • [46] Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan
    Hoshiya, S
    Watanabe, K
    Tokunaga, K
    Tanaka, A
    Ninomiya, H
    Shingaki, M
    Itoh, T
    Saito, S
    Ishida, H
    Takahashi, S
    JOURNAL OF GASTROENTEROLOGY, 2000, 35 (01) : 10 - 14
  • [47] Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori
    Adachi, Teppei
    Matsui, Shigenaga
    Watanabe, Tomohiro
    Okamoto, Kazuki
    Okamoto, Ayana
    Kono, Masashi
    Yamada, Mitsunari
    Nagai, Tomoyuki
    Komeda, Yoriaki
    Minaga, Kosuke
    Kamata, Ken
    Yamao, Kentaro
    Takenaka, Mamoru
    Asakuma, Yutaka
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kashida, Hiroshi
    Kudo, Masatoshi
    ONCOLOGY, 2017, 93 : 15 - 19
  • [48] Primary antibiotics resistance of Helicobacter pylori and eradication rate with clarithromycin-based triple drug therapy in Hong Kong
    Li, Ernest Han Fai
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 230 - 230
  • [49] One-week once-daily triple therapy with esomeprazole, moxifloxacin and rifabutin is effective in the treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin
    Miehlke, Stephan
    Scluicider-Brachert, Wulf
    Morgner, Andrea
    Madisch, Ahmed
    Kirsch, Christian
    Baestlein, Elke
    Haferland, Christian
    Jebens, Claus
    Knoth, Holger
    Stolte, Manfred
    Lehn, Norbert
    GASTROENTEROLOGY, 2006, 130 (04) : A93 - A93
  • [50] Resistance to metronidazole, clarithromycin, and amoxicillin of Helicobacter pylori strains isolated before and after eradication in children
    Gosciniak, G.
    Iwanczak, B.
    Iwanczak, F.
    Grabinska, J.
    HELICOBACTER, 2006, 11 (04) : 401 - 401
12345